Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study
Abstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progester...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Fertility Research and Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40738-020-00079-y |
id |
doaj-34b5bf739555488d9b9a0d8dc2b6c348 |
---|---|
record_format |
Article |
spelling |
doaj-34b5bf739555488d9b9a0d8dc2b6c3482020-11-25T03:41:16ZengBMCFertility Research and Practice2054-70992020-07-01611610.1186/s40738-020-00079-yIntramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort studyJennifer B. Bakkensen0Catherine Racowsky1Ann M. Thomas2Andrea Lanes3Mark D. Hornstein4Department of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolDepartment of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical SchoolAbstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progesterone (IMP) is superior to twice daily vaginal Endometrin suppositories for luteal phase support, resulting in significantly higher ongoing pregnancy rates. This study aimed to determine whether IMP is similarly superior to 8% Crinone vaginal gel for luteal phase support following blastocyst CET. Methods Autologous and donor oocyte blastocyst cryopreserved single embryo transfer (SET) cycles from January 2014–January 2019 utilizing either 50 mg IMP daily or 90 mg 8% Crinone gel twice daily for luteal support were included. The primary outcome was live birth. Secondary outcomes included biochemical pregnancy, spontaneous abortion, and clinical pregnancy. All analyses were adjusted a priori for oocyte age. Log-binomial regression analysis was performed with differences in outcomes reported as relative risk (RR) with 95% confidence intervals (CI). Results A total of 1710 cycles were included, of which 1594 utilized IMP and 116 utilized 8% Crinone gel. Demographic and cycles characteristics were similar between the two groups. Compared to cycles utilizing IMP, cycles utilizing Crinone gel resulted in similar rates of live birth (RR 0.91; 95% CI 0.73–1.13), biochemical pregnancy (RR 1.12, 95% CI 0.65–1.92), spontaneous abortion (RR 1.41, 95% CI 0.90–2.20), and clinical pregnancy (RR 1.00, 95% CI 0.86–1.17). Conclusions Compared to cryopreserved blastocyst SET cycles utilizing IMP for luteal support, cycles utilizing 8% Crinone gel resulted in similar likelihood of live birth.http://link.springer.com/article/10.1186/s40738-020-00079-yLuteal supportIntramuscular progesteroneVaginal progesteroneCrinoneIVFCryo embryo transfer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jennifer B. Bakkensen Catherine Racowsky Ann M. Thomas Andrea Lanes Mark D. Hornstein |
spellingShingle |
Jennifer B. Bakkensen Catherine Racowsky Ann M. Thomas Andrea Lanes Mark D. Hornstein Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study Fertility Research and Practice Luteal support Intramuscular progesterone Vaginal progesterone Crinone IVF Cryo embryo transfer |
author_facet |
Jennifer B. Bakkensen Catherine Racowsky Ann M. Thomas Andrea Lanes Mark D. Hornstein |
author_sort |
Jennifer B. Bakkensen |
title |
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
title_short |
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
title_full |
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
title_fullStr |
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
title_full_unstemmed |
Intramuscular progesterone versus 8% Crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
title_sort |
intramuscular progesterone versus 8% crinone vaginal gel for luteal phase support following blastocyst cryopreserved single embryo transfer: a retrospective cohort study |
publisher |
BMC |
series |
Fertility Research and Practice |
issn |
2054-7099 |
publishDate |
2020-07-01 |
description |
Abstract Background The optimal route of progesterone administration for luteal support in cryopreserved embryo transfer (CET) has been the subject of much debate. While most published research has pertained to day 3 transfers, recent data on blastocyst CET has suggested that intramuscular progesterone (IMP) is superior to twice daily vaginal Endometrin suppositories for luteal phase support, resulting in significantly higher ongoing pregnancy rates. This study aimed to determine whether IMP is similarly superior to 8% Crinone vaginal gel for luteal phase support following blastocyst CET. Methods Autologous and donor oocyte blastocyst cryopreserved single embryo transfer (SET) cycles from January 2014–January 2019 utilizing either 50 mg IMP daily or 90 mg 8% Crinone gel twice daily for luteal support were included. The primary outcome was live birth. Secondary outcomes included biochemical pregnancy, spontaneous abortion, and clinical pregnancy. All analyses were adjusted a priori for oocyte age. Log-binomial regression analysis was performed with differences in outcomes reported as relative risk (RR) with 95% confidence intervals (CI). Results A total of 1710 cycles were included, of which 1594 utilized IMP and 116 utilized 8% Crinone gel. Demographic and cycles characteristics were similar between the two groups. Compared to cycles utilizing IMP, cycles utilizing Crinone gel resulted in similar rates of live birth (RR 0.91; 95% CI 0.73–1.13), biochemical pregnancy (RR 1.12, 95% CI 0.65–1.92), spontaneous abortion (RR 1.41, 95% CI 0.90–2.20), and clinical pregnancy (RR 1.00, 95% CI 0.86–1.17). Conclusions Compared to cryopreserved blastocyst SET cycles utilizing IMP for luteal support, cycles utilizing 8% Crinone gel resulted in similar likelihood of live birth. |
topic |
Luteal support Intramuscular progesterone Vaginal progesterone Crinone IVF Cryo embryo transfer |
url |
http://link.springer.com/article/10.1186/s40738-020-00079-y |
work_keys_str_mv |
AT jenniferbbakkensen intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy AT catherineracowsky intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy AT annmthomas intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy AT andrealanes intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy AT markdhornstein intramuscularprogesteroneversus8crinonevaginalgelforlutealphasesupportfollowingblastocystcryopreservedsingleembryotransferaretrospectivecohortstudy |
_version_ |
1724530688440401920 |